Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
AD-17002 by Advagene Biopharma for Asthma: Likelihood of Approval
AD-17002 is under clinical development by Advagene Biopharma and currently in Phase II for Asthma. According to GlobalData, Phase II...
Data Insights
AD-17002 by Advagene Biopharma for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval
AD-17002 is under clinical development by Advagene Biopharma and currently in Phase III for Coronavirus Disease 2019 (COVID-19). According to...